Due to the increased usage of home test kits to detect coronavirus infection, the Brihanmumbai Municipal Corporation (BMC) has issued new guidelines to manufacturers, suppliers, and sellers of home antigen testing kits in the city.
The civic body instructed people in charge of manufacturing, supplying, and selling home antigen testing kits to email certain details to the civic authorities and the Food and Drug Administration (FDA) in a prescribed format every day, in an order issued on Thursday.
The results of all COVID-19 tests performed using rapid antigen test kits or home test kits must be reported to the Indian Council of Medical Research (ICMR) by laboratories or individuals utilizing mobile applications, according to the order.
The civic body also stated that in some cases, the results of home test kits have not been reported to the ICMR, causing authorities to lose track of patients, leading to the spread of the infection.
“Hence, it is necessary to keep track of such persons to contain the spread of the covid-19 virus,” the BMC order stated.
Under the new guidelines, manufacturers and distributors of home testing kits are required to provide the FDA commissioner and the civic body with information on the number of kits sold to pharmacies and medical stores in Mumbai.
Chemists and medical retailers have been instructed to email data of test kits sold to customers in a prescribed format by 6 PM every day.
According to the guidelines, the FDA commissioner will monitor the distribution and sale of kits at all pharmacists and medical stores in Mumbai and instruct them to notify customers to report the test results on the given app.
The order also specified the roles of the BMC’s epidemiology cell and ward teams.
The epidemiology cell will be responsible for monitoring data received via email from manufacturers, distributors, chemists, pharmacies, medical stores, and other sources and forwarding it to the relevant ward and medical officers of health for further action.
Ward teams will ensure that people upload their test results to the ICMR website or application and that patients’ health is monitored, according to the order.